A NON-INTERVENTIONAL, RETRO-PROSPECTIVE,
MULTICENTER, SINGLE ARM STUDY EVALUATING THE
EFFECTIVENESS AND SAFETY OF MOSUNETUZUMAB IN
PATIENTS WITH FOLLICULAR LYMPHOMA WHO
RECEIVED AT LEAST TWO PRIOR LINES OF SYSTEMIC
THERAPY - SUNRISE STUDY
Sede dell’iniziativa:
Torino
Periodo di svolgimento dell’iniziativa:
Ottobre 3, 2024 -